Ping An Biomedical Co., Ltd.
NASDAQ: PASW · CONSUMER CYCLICAL · TEXTILE MANUFACTURING
Updated 2026-04-30
Ping An Biomedical Co., Ltd. (PASW) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for PASW.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
PASW historical valuation range
Where current P/E sits in PASW's own 5Y range.
PASW intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
PASW valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
P/S Ratio — History
Current: 0.61x
Is PASW overvalued in 2026?
Ping An Biomedical Co., Ltd. (PASW) currently trades at $0.16 per share with a market capitalization of $20,675,300.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 23/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
PASW currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 0.6x, the market is valuing the company primarily on its revenue rather than its earnings.
Our discounted cash flow model estimates PASW's intrinsic value at $0.38 per share, against the current market price of $0.16. This implies a margin of safety of +36.68%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: PASW appears richly valued on our framework, with a Smart Value Score of 23/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is PASW overvalued in 2026?
Based on a Smart Value Score of 23/100, PASW appears overvalued. Current price exceeds what fundamentals currently justify.
What is PASW's fair value?
Our DCF model estimates PASW's intrinsic value at $0.38 per share, versus the current price of $0.16. This produces a margin of safety of +36.68%.
What P/E ratio does PASW trade at?
PASW does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.
Is PASW a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 23/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does PASW's valuation compare to its history?
Insufficient historical valuation data exists yet for a confident percentile read on PASW.
What is PASW's Smart Value Score?
PASW's Smart Value Score is 23/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.